Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Edema Following Branch Retinal Vein Occlusion”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Testing effectiveness (Phase 2)Study completedNCT06664502
What this trial is testing

A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

Who this might be right for
Diabetic Macular Edema (DME)Neovascular Age-related Macular Degeneration (NVAMD)BRVO - Branch Retinal Vein Occlusion
EyeBiotech Ltd. 38
Large-scale testing (Phase 3)Study completedNCT01512901
What this trial is testing

Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)

Who this might be right for
Macular Edema Following Branch Retinal Vein Occlusion
Santen Pharmaceutical Co., Ltd.
Post-approval studies (Phase 4)UnknownNCT03892434
What this trial is testing

Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO

Who this might be right for
Branch Retinal Vein Occlusion With Macular Edema
Yeungnam University College of Medicine 40
Testing effectiveness (Phase 2)Looking for participantsNCT07205887
What this trial is testing

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

Who this might be right for
Neovascular Age-Related Macular Degeneration (NVAMD)Branch Retinal Vein Occlusion (BRVO)
EyeBiotech Ltd. 160
Large-scale testing (Phase 3)Study completedNCT01396057
What this trial is testing

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Visual ImpairmentMacular EdemaBranch Retinal Vein Occlusion
Novartis Pharmaceuticals 244
Large-scale testing (Phase 3)UnknownNCT01189526
What this trial is testing

Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Branch Retinal Vein Occlusion
Seoul Retina Investigator Group 60
Post-approval studies (Phase 4)Study completedNCT03709745
What this trial is testing

Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion with Macular Edema
St. Erik Eye Hospital 110
Post-approval studies (Phase 4)Study completedNCT01580020
What this trial is testing

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Who this might be right for
Retinal Vein Occlusion
Novartis Pharmaceuticals 175